Surviving crises
as filed7.0/10
Has it survived what it has been through?
No warning events in its filings since 2017.
weight 45% of this tense · 70th percentile among 174 sector filers · read for itself
From the record
Omega Healthcare Investors Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Track record
as filed4.7/10
What has it actually done, year after year?
+3.1% a year over 10 filed years; profitable in 10 of 10.
weight 33% of this tense · 47th percentile among 156 sector filers · read for its customers
From the record
Omega Healthcare Investors Inc.'s 10 filed years say what it did: revenue went from $901 million in fiscal 2016 to $1.2 billion in fiscal 2025, up 3.1% a year; it rose in 6 of 9 years; the deepest fall was 17% from fiscal 2021 to fiscal 2022; net income was positive in 10 of 10 of those years (its annual reports).
What it rests on
- revenue growth over the filed span3.1%bottom 32% of its family
- the share of years revenue rosebottom 34% of its family
- the share of filed years with a profittop 20% of its family
- the deepest fall from a revenue peak17.4%bottom 43% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Shareholder treatment
as filed5.2/10
How has it treated the people who own it?
Share count grew 7.7% a year. 94% of cash flow returned. Insiders: 0 sales, 2 purchases.
weight 22% of this tense · 52nd percentile among 156 sector filers · read for its shareholders
From the record
Over the 3 fiscal years to 2025-12-31, Omega Healthcare Investors Inc.'s diluted share count grew about 7.7% a year, and dividends and buybacks returned about 94% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 2 purchases of their own stock on the open market in the year to 2026-10-01, buying about $1 million (their Form 4 filings).
What it rests on
- the share count over the yearsbottom 23% of its family
- cash returned against operating cash flowtop 20% of its family
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.